Browse the full directors' dealings record of Defence Therapeutics Inc., a listed issuer based in Canada. Shares trade on CA CA, under the supervision of SEDI. Market capitalisation: €21.8m. The latest transaction was reported on 12 June 2026 (50 - Grant of options). Among the most active insiders: Beaver, John David. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations